• All
  • Executive Search
  • Finance
  • M&A
  • Views

Proceeds Will Support Clinical Advancement of SB-01 For Injection for Treatment of Degenerative Disc Disease NEW YORK, March 28, 2022 /PRNewswire/ -- Spine BioPharma, Inc., a biopharmaceutical company committed to developing non-opiate, non-surgical therapies for the...

/PRNewswire/ -- HAPPE Spine, an emerging leader in the development of next generation orthopedic and spinal implants enabled by the HAPPE™ material platform, announces strategic new additions to its Board of Directors....

CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today...